333 related articles for article (PubMed ID: 23435144)
1. Preoperative transarterial chemoembolization for hepatocellular carcinoma.
Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
Hepatogastroenterology; 2012 Oct; 59(119):2295-9. PubMed ID: 23435144
[TBL] [Abstract][Full Text] [Related]
2. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
3. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
4. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
6. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
8. Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors.
Shi HY; Wang SN; Wang SC; Chuang SC; Chen CM; Lee KT
J Surg Oncol; 2014 Apr; 109(5):487-93. PubMed ID: 24293372
[TBL] [Abstract][Full Text] [Related]
9. Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection.
Paik KY; Kim EK
Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):158-64. PubMed ID: 27020632
[TBL] [Abstract][Full Text] [Related]
10. The effect of postoperative TACE on prognosis of HCC with microscopic venous invasion.
Ke-Wei L; Tian-Fu W; Xi L; Lü-Nan Y; Bo L; Yong Z; Wu-Sheng L; Wen-Tao W; Ming-Qing X; Jia-Yin Y; Yu-Kui M; Zhe-Yu C
Hepatogastroenterology; 2012 Sep; 59(118):1944-6. PubMed ID: 22246191
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
13. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
[TBL] [Abstract][Full Text] [Related]
14. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
[TBL] [Abstract][Full Text] [Related]
15. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
[TBL] [Abstract][Full Text] [Related]
16. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD
World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
[TBL] [Abstract][Full Text] [Related]
20. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.
Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP
Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
